Profluent, which wants to use AI for protein design in drug discovery, raised $106M led by Bezos Expeditions and Altimeter, bringing its total funding to $150M (Amy Feldman/Forbes)
Amy Feldman / Forbes: Profluent, which wants to use AI for protein design in drug discovery, raised $106M led by Bezos Expeditions and Altimeter, bringing its total funding to $150M — Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.
Amy Feldman / Forbes:
Profluent, which wants to use AI for protein design in drug discovery, raised $106M led by Bezos Expeditions and Altimeter, bringing its total funding to $150M — Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.
This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.
